Abnormal oscillation in the brain causes motor deficits in Parkinson's disease

The research group headed by Professor Atsushi Nambu (The National Institute for Physiological Sciences) and Professor Masahiko Takada (Primate Research Institute, Kyoto University) has shown that the 'oscillatory' nature of electrical signals in subcortical nuclei, the basal ganglia, causes severe motor deficits in Parkinson's disease, by disturbing the information flow of motor commands. The group also found that chemical inactivation of the subthalamic nucleus (a structure of the basal ganglia) in parkinsonian monkeys improved the motor impairments by reducing the 'oscillations.' The results of this study were reported in European Journal of Neuroscience, November 2011 issue.

 A member of the research group, Assistant Professor Yoshihisa Tachibana, succeeded to record in monkey basal ganglia neurons under unanesthetized conditions. The group found that neurons in the parkinsonian basal ganglia showed abnormal 'oscillatory' activity, which was rarely seen in normal subjects. The abnormal rhythm was completely eliminated by systemic administration of a dopamine precursor (L-DOPA), which is clinically used for human parkinsonian patients. The group considered that loss of dopamine induced the 'oscillations' in the basal ganglia and that the following disturbances in information flow of motor commands impaired motor performances. Abnormal neuronal oscillations were already reported in parkinsonian patients and animal models, but this report has provided the direct evidence that 'oscillations' are associated with motor abnormalities. Moreover, it was also shown that the injection of a chemical inhibitor, muscimol, into the subthalamic nucleus silenced the oscillatory signals, and eventually reversed parkinsonian motor signs.

Professor Nambu claims, "By investigating the 'oscillatory' nature of electrical signals in the , we can advance our understanding of the pathophysiology of Parkinson's disease. We improved motor deficits by means of infusion of the chemical inhibitor (muscimol) into the to silence the 'oscillatory' signals in the brain structure. This may provide us important clues to developing new treatments for Parkinson's disease."

Related Stories

Unconscious learning uses old parts of the brain

date Apr 06, 2010

(PhysOrg.com) -- A new study from the Swedish medical university Karolinska Institutet provides evidence that basic human learning systems use areas of the brain that also exist in the most primitive vertebrates, such as ...

Recommended for you

AAN: phenytoin neuroprotective in optic neuritis

date 19 hours ago

(HealthDay)—Phenytoin appears to be neuroprotective in acute optic neuritis (AON), according to a study scheduled to be presented at the annual meeting of the American Academy of Neurology, held from April ...

How a jab to the ribs jolts the brain into action

date 23 hours ago

A short jab in the ribs instantly arouses a drowsy colleague during a long and dreary work meeting. A new study by Yale neurobiologists describes just what happens in the brain immediately following that ...

How do we hear time within sound?

date Apr 16, 2015

How does our auditory system represent time within a sound? A new study published in PLOS Computational Biology investigates how temporal acoustic patterns can be represented by neural activity within audito ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.